The Path to Progress: Glucagon-like Peptide 1 Agonists, Individualized Care, and Overcoming Goal-Directed Medical Therapy Barriers in Diabetes and CKD - Sophia L. Ambruso; Matthew R. Weir (Kidney International Reports)